Novo Nordisk partners e-recruitment firm to boost diabetes trial numbers

By Dan Stanton

- Last updated on GMT

Related tags Novo nordisk Patient recruitment Recruitment

Traditional newspaper ads becoming less relevant in patient recruitment, says Trialbee
Traditional newspaper ads becoming less relevant in patient recruitment, says Trialbee
Novo Nordisk has selected patient recruitment firm Trialbee to boost participant numbers in diabetes studies using its web-based platform.

The Danish pharma firm will use the e-recruitment programme for an initial four type 1 and type 2 diabetes studies in Denmark, Sweden, and Norway, beginning in the first quarter of this year.

According to Trialbee’s founder and VP of Sales, the firm’s platform is a web-based centralised system that can find and match patients to entire clinical trials - both nationally and internationally – and will be used by Novo Nordisk in parallel with traditional recruitment techniques.

“Traditional patient recruitment is turned out by the investigator and usually involve individual websites and newspaper adverts,”​ he told This in-house recruitment process is decentralised, he continued, and can be a far too long a procedure.

Trialbee, however, communicates directly with the patient groups using a range of digital media, web and mobile applications and social media sites. “Turning directly to the patient groups,”​ Billing said, “leads to a step-by-step qualification which is more certain in the recruitment process than traditional methods.”

Though there are other players in the third-party patient recruitment industry, Billing said the majority of companies using the same space as Trialbee were currently situated and active within the US.

Furthermore, “more traditional recruitment companies usually work with patient databases,”​ he said, which in his opinion “tend to grow old quite quickly, and therefore patients on it might not be available for trials.”

For Novo Nordisk, the implemtation of Trialbee will help ensure trials can start as planned, topping up patient numbers not achieved with traditional techniques.

Though focused on the Nordic area, Billing said Trialbee also has capabilities across Europe. Furthermore, the firm has already completed successful patient recruitment campaigns with Sanofi and Astrellas and is in ongoing discussions with a number of other promising Big Pharma partners.

Related news

Show more

Related products

show more

Saama accelerates data review processes

Saama accelerates data review processes

Content provided by Saama | 25-Mar-2024 | Infographic

In this new infographic, learn how Saama accelerates data review processes. Only Saama has AI/ML models trained for life sciences on over 300 million data...

More Data, More Insights, More Progress

More Data, More Insights, More Progress

Content provided by Saama | 04-Mar-2024 | Case Study

The sponsor’s clinical development team needed a flexible solution to quickly visualize patient and site data in a single location

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Related suppliers

Follow us


View more